Global Retirement Partners’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$42.8K Hold
1,100
﹤0.01% 2447
2025
Q3
$25K Sell
1,100
-63
-5% -$1.28K ﹤0.01% 2289
2025
Q2
$23.7K Buy
+1,163
New +$21.5K ﹤0.01% 2201
2024
Q4
$29.3K Hold
1,100
﹤0.01% 1873
2024
Q3
$31.4K Hold
1,100
﹤0.01% 1776
2024
Q2
$23.9K Hold
1,100
﹤0.01% 1890
2024
Q1
$24.4K Sell
1,100
-5
-0.5% -$109 ﹤0.01% 1726
2023
Q4
$21.4K Buy
1,105
+1,078
+3,993% +$19K ﹤0.01% 1726
2023
Q3
$416 Hold
27
﹤0.01% 3001
2023
Q2
$370 Hold
27
﹤0.01% 3012
2023
Q1
$619 Sell
27
-50
-65% -$1.22K ﹤0.01% 2875
2022
Q4
$1.81K Hold
77
﹤0.01% 2392
2022
Q3
$2K Hold
77
﹤0.01% 2214
2022
Q2
$2K Hold
77
﹤0.01% 2175
2022
Q1
$2K Buy
77
+27
+54% +$1.12K ﹤0.01% 2159
2021
Q4
$2K Hold
50
﹤0.01% 215
2021
Q3
$3K Hold
50
﹤0.01% 1740
2021
Q2
$4K Hold
50
﹤0.01% 1614
2021
Q1
$3K Sell
50
-331
-87% -$24.9K ﹤0.01% 1574
2020
Q4
$26K Hold
381
﹤0.01% 950
2020
Q3
$20K Buy
381
+180
+90% +$8.01K ﹤0.01% 922
2020
Q2
$8K Hold
201
﹤0.01% 1161
2020
Q1
$6K Sell
201
-900
-82% -$27.2K ﹤0.01% 1160
2019
Q4
$38K Buy
+1,101
New +$26.9K 0.01% 708

Other funds holding CSTL

Global Retirement Partners's CSTL Position: Q4 2025 in Review

Global Retirement Partners held its Castle Biosciences (CSTL) position steady in Q4 2025 at 1,100 shares worth $42.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Global Retirement Partners first reported a position in CSTL in Q4 2019 and has held it in 24 quarters since. 194 funds tracked by Wall St. Rank hold CSTL as of Q4 2025.

  • Global Retirement Partners held 1,100 shares of Castle Biosciences worth $42.8K as of Q4 2025.
  • Global Retirement Partners left its Castle Biosciences share count unchanged in Q4 2025.
  • Castle Biosciences made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2447 holding.
  • Global Retirement Partners first reported a position in Castle Biosciences in Q4 2019 and has held it in 24 quarters since.
  • 194 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.